In fact, the Gem@TpHResMic had a greater potential to damage DNA than the free Gem, and this was reflected in the increased induction of apoptosis and persistent perturbation of the cell cycle, which may prove to be a useful strategy to target those cancer cells that use mitotic slippage as a drug rescue mechanism. Here, GEM is linked to cancer.